| Business Summary |
| The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins. |
| General Information |
73
High Street
Buffalo, NY 14203
|
| www.cbiolabs.com |
| Industry : Diversified Services |
| Sector: Services |
| Employees: 33 |
| CEO: Dr. Michael Fonstein, Ph |
| Short Interest |
| Current Month (Mil) |
0.44 |
| Previous Month (Mil) |
0.43 |
| Short Interest Ratio (Days) |
5.10 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-258.10 |
| Return on Investments |
175.00 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet